Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
InSightec
NaviFUS Corporation
NaviFUS Corporation
Jecho Biopharmaceuticals Co., Ltd.
Ariceum Therapeutics GmbH
NovoCure Ltd.
InSightec
InSightec
Eli Lilly and Company
CureVac
InSightec
Mundipharma Research Limited
Enterome
Eli Lilly and Company
Merck Sharp & Dohme LLC
GC Cell Corporation
Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc.
Alaunos Therapeutics
Boehringer Ingelheim
Incyte Corporation
Alaunos Therapeutics
InSightec
Istari Oncology, Inc.
PharmaMar
Alpheus Medical, Inc.
SonoClear AS
BioMimetix JV, LLC
Istari Oncology, Inc.
Engeneic Pty Limited
Hoffmann-La Roche
MediciNova
Bayer
Alaunos Therapeutics
Cordgenics, LLC
Bristol-Myers Squibb
Kazia Therapeutics Limited
Candel Therapeutics, Inc.
BeiGene
Stemline Therapeutics, Inc.
BerGenBio ASA
Clinical Laserthermia Systems AB
Taproot Health
Blueprint Medicines Corporation
Everfront Biotech Co., Ltd.
NovoCure Ltd.
Prelude Therapeutics
Basilea Pharmaceutica
ImmunityBio, Inc.